Stay updated on Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page.

Latest updates to the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed, indicating an internal site version update. No substantive study content or functionality changes are evident on the page.SummaryDifference0.1%

- Check25 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-status notice and Revision: v3.4.1.SummaryDifference0.5%

- Check61 days agoChange DetectedThe page displays a government funding lapse notice and a site status message. The release note updates from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check68 days agoChange DetectedAdded a glossary toggle and updated QC metadata to revision 3.4.0 (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data').SummaryDifference0.2%

- Check82 days agoChange DetectedA revision note shows the page version updated from v3.3.3 to v3.3.4, with no changes to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page.